• Magazine
  • ENEWS
  • SUBSCRIBE
  • WEBINARS
  • PODCASTS
  • EBOOKS
  • Home >
  • Sector

    • API

    Active Pharmaceutical Ingredients (APIs) are combined with excipients (inactive substances) to make drugs.  Here you will find content about the development, manufacturing, analysis and regulation of pharmaceutical APIs.

    Articles

    Screen Shot 2023 09 06 At 11 17 20 Am

    Bridging the gap between R&D and GMP

    Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success
    PM2208-HERO-575x327-Development

    Toward a collaborative pharma ecosystem

    A new biomanufacturing era demands that suppliers and manufacturers partner to efficiently bring new therapies to market
    final-may

    Reevaluating pharma packaging priorities

    Supply chain challenges and industry trends are spurring new business strategies
    india

    Global Dose: Focus on India

    The world's leader of generic drug production looks towards new horizons in pharma
    PM2101-Predictions-Logo

    Top pharma industry predictions for 2021

    In many ways, the beginning of 2021 isn’t just one of the most welcome New Years of the modern era — it could also be a turning point between the pre-COVID and post-COVID worlds...
    powder

    The case for nanoparticles

    Leveraging new powder technologies to manufacture personalized medicines
    shutterstock-1734037067

    Manufactured patriotism

    The government wants to reshore generics, but the drug industry isn’t celebrating
    lab

    Harnessing lab power on the pharma plant floor

    Technologies accelerating the verification process for raw materials
    PM2009-HERO-880x500-CoverStory2

    Bring it home

    Inside the movement to put generic drug production back on America's shores
    ships

    The growing benefits to reshoring pharma operations

    The need to explore the diversification of U.S. pharmaceutical supply chains and the feasibility of relocation has never been higher.
    Screen-Shot-2020-04-20-at-1.23.32-PM

    Driving excipient innovation

    Overcoming regulatory constraints surrounding novel excipients can elevate the entire industry
    Thermo-FIgure1

    Innovation in excipient analysis

    How modern techniques are helping pharma overcome excipient analysis hurdles
    PM1912-Syringe-Butterfly

    Carcinogenic butterflies

    Recent recalls may alter the path of quality in pharma
    PM1912-AwardHero-880x500

    The recall effect

    How the blood pressure debacle is rippling through the industry
    Traditional-chemocatalysis

    The evolution of API route decisions

    How advancements in biocatalytic capabilities have added to the API development and manufacturing toolbox